Journal of AdvancedMedical and Dental Sciences Research

Background:Diabetes Mellitus (DM) is a global metabolic disorder that impacts people worldwide. It gives rise to Neuropathy, leading to notable morbidity characterized by symptoms such as Paraesthesia, hyperesthesia, gait disturbance, distal weakness, insensitive extremities, and a heightened susceptibility to foot ulcers, potentially resulting in amputations. The pain associated with diabetic neuropathy significantly affects the overall quality of life. Early diagnosis and management of diabetic neuropathy through tools like Diabetic Neuropathy Examination Scoring (DNE Scoring) and Electrophysiological studies (NCV study) are instrumental in reducing the morbidity associated with DM.Methods:Over the course of one year, 104 patients within the age range of 40 to 90 years were comprehensively examined. The assessment involved a thorough review of medical histories, detailed clinical examinations using DNE scoring, and Neuroconduction Velocity (NCV) studies.Results and conclusion:The combined utilization of NCV testing and DNE Scoring proves instrumental in early diagnosis, effective management, and slowing down the progression of diabetic neuropathy by achieving better control. The optimal diagnosis of Diabetic Sensorimotor Polyneuropathy (DSPN) is established through a comprehensive evaluation of both clinically observed symptoms and corresponding electrophysiological alterations. The synergy between Diabetic Neuropathic Examination (DNE scoring) and its alignment with NCV findings enhances the early detection capabilities for diabetic neuropathy.